Harlan F. Weisman, CEO, Coronado Biosciences
Burlington, Mass.-based biopharmaceutical company Coronado Biosciences Inc. (Nasdaq:CNDO) saw its stock jump 7 percent after announcing it raised $9.9 million, after deducting commission, in an at-the-market public offering of stock.
The sale of 1 million shares to Jennison Associates LLC at Wednesdays closing price of $10.12 was administered through ...
↧